Skip to content
Screener

Haemonetics HAE Payments to Acquire Property, Plant, and Equipment

Payments to Acquire Property, Plant, and Equipment at other companies

TFX
TeleflexTFX
$14.03M-49.5%
LivaNova logo
LivaNovaLIVN
$31.55M+108%
Solventum logo
SolventumSOLV
$83M-24.5%
Repligen logo
RepligenRGEN
$5.33M-24.9%
Medtronic logo
MedtronicMDT
Merit Medical Systems logo
Merit Medical SystemsMMSI

Other financials

Income statement

See full
Revenue$339.4M+5.6%
Gross profit$202.8M+5.5%
Operating income$57.5M+6.7%
Net income$33.0M-3.0%
EPS (diluted)$0.72+2.9%

Balance sheet

See full
Cash & equivalents$223.4M-23.7%
Total debt$1.2B-4.1%
Total equity$837.1M-5.1%
Total assets$2.4B-3.9%

Cash flow

See full
Operating cash flow$52.3M+201%
CapEx$7.9M+111%
Free cash flow$44.4M+226%

Valuation

See full
Market cap$4B+58.1%
Enterprise value$4.95B+43.0%
P/E26.6×-10.9×
P/S+1.1×

Profitability

See full
Gross margin59%+2.1pp
Operating margin19%+5.9pp
Net margin13.3%+3.8pp
FCF margin21.5%+7.5pp

Returns & leverage

See full
Return on equity19.3%+5.2pp
Debt / equity1.4×0.0×
Current ratio3.1×+1.4×

Where this comes from

Reported directly by Haemonetics in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The source filing: Haemonetics’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 6:09 AM EDT
Fiscal quarter
Q1 FY2027
Calendar quarter
Q2 2026
Accession
0000313143-26-000120
Line itemThree Months Ended / June 27, 2026Three Months Ended / June 28, 2025
Change in accounts payable and accrued expenses(12,615)(47,896)
Net cash provided by operating activities52,32317,395
Cash Flows from Investing Activities:
Capital expenditures(7,906)(3,754)
Non-cash transfers from inventory to property, plant and equipment for Haemonetics equipment(5,565)(11,460)
Proceeds from sale of property, plant and equipment237297
Other investments(9,000)(18,083)
Net cash used in investing activities(22,234)(33,000)

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Haemonetics's payments to acquire property, plant, and equipment?
Haemonetics (HAE) reported payments to acquire property, plant, and equipment of $7.91M in Q2 2026.
How has Haemonetics's payments to acquire property, plant, and equipment changed year-over-year?
Haemonetics's payments to acquire property, plant, and equipment increased by 110.6% year-over-year, from $3.75M to $7.91M.
What is the long-term trend for Haemonetics's payments to acquire property, plant, and equipment?
Over 4 years (2022 to 2026), Haemonetics's payments to acquire property, plant, and equipment has grown at a -23.7% compound annual growth rate (CAGR), from $96.51M to $32.78M.
What does payments to acquire property, plant, and equipment mean?
Payments to Acquire Property, Plant, and Equipment

Ask your AI about Haemonetics's payments to acquire property, plant, and equipment.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude